chartexchange

Ovid Therapeutics Reports Business Updates and Third Quarter 2026 Financial Results

GlobeNewswire Inc. | Nov 10, 2026 7:00 AM EST

NEW YORK, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to pioneering better, gentler medicines for brain disorders with significant unmet need, today provided business updates including financial results for the third quarter ended September 30, 2026.

Read original article